Sandbox GGC12: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (16 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==Serum Albumin== | == Human Serum Albumin== | ||
<StructureSection load='1AO6' size='340' side='right' caption='Serum Albumin Protein' scene='78/781196/00_green_cartoon/1'> | <StructureSection load='1AO6' size='340' side='right' caption='Serum Albumin Protein' scene='78/781196/00_green_cartoon/1'> | ||
Human serum albumin or HSA is one of the major types of proteins that are present in the plasma composition. It is such abundant that its concentration on a common blood sample is 5 grams per 100 milliliters. Due to its high concentration in plasma as well as its physiological and pharmaceutical features, it has been subjected to several studies to determine its 3D structure, function, domains, important binding sites, and diseases. The primary structure of HSA describes a single polypeptide with 585 amino acids with the characteristics of having 17 pairs of disulfide bridges, one free cysteine <ref>PMID: 6275391</ref>. It has been discovered that there are highly conserved sequences between bovine, human and rat albumins such as Trp-212, 143-155 and 244-263 sequence <ref>PMID: 6192439</ref>. It is composed of three domains at positions 19-210, 211-403, and 404-601 with two subdomains each (Ia&b, IIa&b, and IIIa&b). The subcellular location of these protein is the extracellular region on the outside of the cell membrane or secreted. There are 11 metal binding sites, including 1 copper site, 7 calcium sites, 3 zinc sites, additionally, 1 binding site for bilirubin and 1 site for aspirin-acetylated lysine <ref>PMID: 10388840</ref>. | Human serum albumin or HSA is one of the major types of proteins that are present in the plasma composition. It is such abundant that its concentration on a common blood sample is 5 grams per 100 milliliters. Due to its high concentration in plasma as well as its physiological and pharmaceutical features, it has been subjected to several studies to determine its 3D structure, function, domains, important binding sites, and diseases. The primary structure of HSA describes a single polypeptide with 585 amino acids with the characteristics of having 17 pairs of disulfide bridges, one free cysteine <ref>PMID: 6275391</ref>. It has been discovered that there are highly conserved sequences between bovine, human and rat albumins such as Trp-212, 143-155 and 244-263 sequence <ref>PMID: 6192439</ref>. It is composed of three domains at positions 19-210, 211-403, and 404-601 with two subdomains each (Ia&b, IIa&b, and IIIa&b). The subcellular location of these protein is the extracellular region on the outside of the cell membrane or secreted. There are 11 metal binding sites, including 1 copper site, 7 calcium sites, 3 zinc sites, additionally, 1 binding site for bilirubin and 1 site for aspirin-acetylated lysine <ref>PMID: 10388840</ref>. | ||
| Line 7: | Line 7: | ||
== Disease == | == Disease == | ||
HSA is involved in two important diseases, Hyperthyroxinemia, familial dysalbuminemic (FDAH) and Analbuminemia (ANALBA). | |||
First, FDAH is a condition based on the genetic composition of the individual. It is caused by a mutation in the ALB gene, which corresponds to an increased affinity of the protein HSA for thyroxine. In detail, this autosomal dominant genetic disorder is characterized by the mutation of HSA causing the assembly of thyroxine in a higher proportion. There are two positions with three natural variants identified on the HSA that mutate to cause this disorder. The first position (red) is at 90 amino acid, where leucine is replaced by a proline. The second position (green) at 242 amino acid, where arginine is substituted by histidine or proline <scene name='78/781196/Hyperthyroxinemia/1'>3D View</scene>. This disorder could lead to confusion and several misdiagnoses of hyperthyroidism because it is difficult to detect it due to the normal TSH and free thyroxine levels but with an elevated total of thyroxine <ref>PMID: 32665066</ref>. | |||
Second, ANALBA is an uncommon autosomal recessive genetic mutation characterized by the identification of very low levels of HSA circulating in the bloodstream <ref>PMID: 8134387</ref>. The affected individuals have symptoms corresponding to mild edema, hypotension, fatigue, and lower body lipodystrophy in females. The mutagenesis is located in the position 91 where histidine is replaced by alanine impairing metal binding <ref>PMID: 28567254</ref>. The complications of this disorder could lead to early atherosclerosis and heart problems. | |||
== Relevance == | == Relevance == | ||
| Line 13: | Line 17: | ||
== Structural highlights == | == Structural highlights == | ||
The structural highlights of this protein are four: the three domains that compose the protein, the binding site in domain II for salicylates, sulfonamides and several drug ingredients, the bilirubin binding site at position 264, and the free cysteine in the structure of the protein <ref> PMID: 32162429</ref>. | |||
This is | This is the structural view of <scene name='78/781196/3domains/1'>the three domains</scene> by different colors. Digitoxin, cardiac glycoside, could bind domain I for cardiac insufficiency, warfarin, anticouagulant, bind primarily in domain II, and the diazapines like benzodiazapine, muscular relaxor, in domain III. The shared binding site in domain II between zinc and calcium at residue <scene name='78/781196/273_asp/2'>Asp 273</scene> suggests a crosstalk between zinc and calcium transport in the blood. The <scene name='78/781196/264_bili/1'>bilirubin</scene> binding site at position 264, which is significant because it possess important functions as an antioxidant, but it also serves simply as a means to excrete unwanted heme, derived from various heme-containing proteins such as hemoglobin, myoglobin, and various P450 enzymes. <scene name='78/781196/Cys34/1'>Cys 34</scene> located in a loop between helice is the only cysteine residue that does not participate in any disulfide bridges. Its sulfhydryl group is prevented from coupling with the external counterparts giving a structure known as triclinic crystals. Sequence 143 through 155 and sequence 244 through 263 are involved in ligand binding. For example, residues <scene name='78/781196/Sequence/1'>143-155</scene>, an aromatic sequence, corresponds with the region of the second major long-chain fatty acid binding site <ref>PMID: 2155760</ref>. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||